TWB-103 Allogeneic Dermal Fibroblast Cell Therapy Product

Category: Cell Therapy and Regenerative Medicine

Booth No: N602

Characteristic

TWB-103, developed by TRANSWELL BIOTECH CO. LTD., is an allogeneic cell therapy product designed to promote wound healing. It consists of a vial of frozen cells stored at -80℃ and a bottle of hydrogel carrier stored at 4℃. This product is pre-manufactured and can be stored long-term, allowing for ready-to-use; availability in medical institutions. It provides a quick and effective solution for various emergency and severe injury situations.

For clinical treatment. First, thaw and mix the cells and the hydrogel carrier evenly, then apply the mixture to the wound surface. The dermal fibroblasts contained in TWB-103 actively interact with keratinocytes, promoting their proliferation and migration to the wound sites. The skin fibroblasts secrete multiple growth factors and cytokines that regulate immune responses and promote angiogenesis, thereby accelerating wound healing. Additionally, the hydrogel carrier not only maintains cell viability but also keeps the wound moist, reduces pain, and minimizes discomfort during the dressing change process, creating an optimal environment for wound healing.